NERV – minerva neurosciences, inc (US:NASDAQ)
Stock Stats
News
Institutions profited after Minerva Neurosciences, Inc.'s (NASDAQ:NERV) market cap rose US$27m last week but individual investors profited the most [Yahoo! Finance]
Minerva Neurosciences Spotlights Roluperidone, Lays Out Confirmatory Phase 3 Timeline for Schizophrenia [Yahoo! Finance]
Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia Transcript [Seeking Alpha]
Minerva Neurosciences to Host Virtual KOL Event to Discuss Roluperidone: From Unmet Need to Reality – Potentially the First Treatment for Patients with Negative Symptoms of Schizophrenia, on February 3, 2026
Minerva Neurosciences (NASDAQ:NERV) was downgraded by analysts at Wall S
Form SCHEDULE 13G Minerva Neurosciences, Filed by: Coastlands Capital LP
Form SCHEDULE 13G Minerva Neurosciences, Filed by: Logos Global Management LP
Form SCHEDULE 13G Minerva Neurosciences, Filed by: BALYASNY ASSET MANAGEMENT L.P.
Form SCHEDULE 13G Minerva Neurosciences, Filed by: Adage Capital Management, L.P.
Form SCHEDULE 13G/A Minerva Neurosciences, Filed by: Farallon Capital Partners, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.